ClinicalTrials.gg
RecruitingNCT07755696CAPPUCCINOHUpdated Aug 21, 2026

Robotic Single Port Combined Umbilical and Inguinal Hernia Repair

An interventional study of da Vinci Single Port Surgical System and Robotic Single-Port Inguinal and Concomitant Umbilical Hernia Repair in Inguinal Hernia Repair and Umbilical Hernia Repair, sponsored by Algemeen Ziekenhuis Maria Middelares. Recruiting at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-21.

Sponsored by Algemeen Ziekenhuis Maria Middelares · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Apr 2026, registered Aug 2026).
  • Started Apr 2026; still recruiting 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Evaluation of the perioperative and patient reported outcomes of a new surgical technique: robotic inguinal hernia repair using the Da Vinci SP system.

Read the detailed description

The CAPPUCCINOH study (Combined APProach of Umbilical ConComitant with Inguinal Hernia Repair) is a prospective single-centre, single-arm cohort study conducted at AZ Maria Middelares, Ghent, Belgium. The study evaluates a novel surgical technique combining robotic-assisted inguinal hernia repair with concomitant umbilical hernia repair using the da Vinci Single Port (SP) system.

Building on the feasibility demonstrated in the ESPRITH study, the umbilical hernia defect is used as the single access site for the robotic procedure. Following inguinal hernia repair, the umbilical defect is repaired either by primary closure or with preperitoneal mesh reinforcement according to current guidelines and defect size.

The primary objective is to assess the safety and feasibility of this approach by evaluating operative time, technical errors, successful mesh placement, and perioperative complications. Secondary objectives include assessment of patient-reported outcomes, quality of life, body image, and hernia recurrence at one year postoperatively.

Patients will be followed for one year after surgery, with evaluations performed during hospitalization and at one month and one year postoperatively. The study aims to generate clinical evidence on the safety, effectiveness, and patient experience of robotic single-port repair for concomitant inguinal and umbilical hernias.

02

Conditions studied

  • Inguinal Hernia Repair
  • Umbilical Hernia Repair

Keywords

  • Inguinal hernia repair
  • da Vinci SP Surgical System
  • concomitant umbilical hernia
03

In context

Hernia, Inguinal

543 studies on the registry are indexed under Hernia, Inguinal; 92 are open to participants now.

This study's planned enrollment of 30 is below the median of 90 across 395 interventional studies indexed under Hernia, Inguinal.

Browse Hernia, Inguinal studies →

Lead sponsor

Algemeen Ziekenhuis Maria Middelares is the lead sponsor of 37 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults with a primary inguinal hernia, either unilateral or bilateral, in association with a primary umbilical hernia of >1

Exclusion criteria

Exclusion Criteria:

  • recurrent inguinal hernia after preperitoneal repair
  • irreducible scrotal hernia
  • post-prostatectomy
  • laparotomy in the lower abdomen
  • pregnancy
  • for general anaesthesia
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Robotic Single-Port Inguinal and Concomitant Umbilical Hernia Repair

    Device: da Vinci Single Port Surgical System · Procedure: Robotic Single-Port Inguinal and Concomitant Umbilical Hernia Repair

Interventions

  • Deviceda Vinci Single Port Surgical System

    Robotic surgical platform used to perform single-port robotic inguinal hernia repair with concomitant umbilical hernia repair through a single umbilical access site.

  • ProcedureRobotic Single-Port Inguinal and Concomitant Umbilical Hernia Repair

    Robotic single-port inguinal hernia repair with concomitant umbilical hernia repair through a single umbilical access site using the da Vinci SP system.

06

What researchers measure

Primary outcomes

  1. Technical errors with the robotic system

    Number and type of technical errors or device-related issues encountered during the procedure.

    Time frame: During surgery

  2. Operative time

    Total operative time from skin incision to skin closure

    Time frame: During surgery

  3. Complication Rate

    Intraoperative, in-hospital and postoperative complications classified according to the Clavien-Dindo classification

    Time frame: From surgery until 1 month postoperatively

  4. Success rate

    success rate of preperitoneal mesh placement

    Time frame: From surgery until planned follow-up 1 month potoperatively

Secondary outcomes

  1. EuraHS Quality of Life score

    Patient-reported quality of life assessed using the European Registry for Abdominal Wall Hernias Quality of Life (EuraHS-QoL) Questionnaire, a validated instrument evaluating pain at the hernia site, restriction of activities, and cosmetic discomfort. The total EuraHS-QoL score ranges from 0 to 90, with lower scores indicating better quality of life and less symptom burden, and higher scores indicating worse quality of life and greater symptom burden

    Time frame: Preoperatively, 1 month and 1 year postoperatively

  2. Body Image Questionnaire Score

    Patient-reported body image assessed using the Body Image Questionnaire. The questionnaire evaluates patient satisfaction with physical appearance and cosmetic outcomes

    Time frame: Preoperatively, 1 month , and 1 year postoperatively

  3. Number of Participants With Hernia Recurrence

    Number of participants with a recurrent ventral hernia within 1 year after surgery. Hernia recurrence will be assessed clinically and confirmed by ultrasound when clinically indicated.

    Time frame: 1 year postoperatively

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07755696
Lead sponsor
Algemeen Ziekenhuis Maria Middelares
Responsible party
Filip Muysoms (Head of Surgery Department, Algemeen Ziekenhuis Maria Middelares) — Principal investigator
First posted
Aug 10, 2026
Start date
Apr 1, 2026
Primary completion
Apr 1, 2028 (estimated)
Completion
Apr 1, 2029 (estimated)
Last update
Aug 21, 2026

Study contacts

Filip Muysoms, MD, PhD
Contact
filip.muysoms@gmail.com
+32477325710
Jolien Lansens, Sc
Contact
Jolien.Lansens@mijnziekenhuis.be
+3292461854

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion